Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
methylphenidate (ritalin) (1 trial)
bevacizumab (avastin) (1 trial)
capecitabine (xeloda) (1 trial)
doxorubicin (Doxil) (1 trial)
paclitaxel (taxol) (1 trial)
vitamin d3 (1 trial)
Breast Neoplasms (Phase 3)
Cognitive Dysfunction (Phase 4)
Trials (3 total)
Trial APIs (6 total)